AI and 3D Printing Could Streamline Generic Drug Formulation, Potentially Lowering Costs and Expanding Access

Technological advancements are reshaping the landscape of generic drug development, introducing innovations like AI-powered formulation and 3D printing. A recent article from DrugPatentWatch explores these impacts, noting potential for more efficient development processes, reduced costs, and increased accessibility to essential medications. The DrugPatentWatch article details how artificial intelligence can refine drug formulations, streamlining the development phase. Furthermore, it highlights 3D printing’s potential to revolutionize drug manufacturing, offering new avenues for creating generic medications. These advancements collectively point towards a future where generic drugs can be produced more efficiently and affordably, potentially broadening access to life-saving treatments for a wider population.

Newsflash | Powered by GeneOnline AI
Date: April 10, 2025

Author

Mark Chiang